Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: A randomized controlled trial

American Journal of Nephrology

Volumn 37, Issue 1, 2013, Pages 84-90

  Ren, Hong ^a   Shen, Pingyan ^a   Li, Xiao ^a   Pan, Xiaoxia ^a   Zhang, Wen ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cyclophosphamide; Focal segmental glomerulosclerosis; Nephrotoxicity; Tacrolimus

Indexed keywords

AMINOTRANSFERASE; CYCLOPHOSPHAMIDE; GLUCOSE; PREDNISONE; TACROLIMUS;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ATOPIC DERMATITIS; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MONITORING; DRUG SAFETY; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HERPES ZOSTER; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; KIDNEY FUNCTION; LUNG INFECTION; MALE; MENSTRUATION DISORDER; NAUSEA AND VOMITING; OPEN STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; SEPSIS; SIDE EFFECT; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ADULT; ALBUMINS; CYCLOPHOSPHAMIDE; FEMALE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MALE; PROSPECTIVE STUDIES; PROTEINURIA; RECURRENCE; REMISSION INDUCTION; TACROLIMUS; TREATMENT OUTCOME;

EID: 84872824172     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000346256     Document Type: Article

References (20)

1. Rich AR: A hitherto undescribed vulnerability of the juxtamedullary glomeruli in lipoid nephrosis. Bull Johns Hopkins Hosp 1957; 100: 173
2. Kitiyakara C, Kopp JB, Eggers P: Trends in the epidemiology of focal segmental of glomerulosclerosis. Semin Nephrol 2003; 23: 172-182
3. Zhou F, Zhao M, Zou W, et al: The changing spectrum of primary glomerular diseases within 15 years: a survey of 3,331 patients in a single Chinese centre. Nephrol Dial Transplant 2009; 24: 870-876
4. Korbet SM: Angiotension anagonists and steroids in treatment of focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: 219-228
5. Braun N, Schmutzler F, Lange C, et al: Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 16: CD003233
6. Ponticelli C, Passerini P: Other Immunosuppressive agents for focal segmental glomerulosclerosis. Semin Nephrol 2003; 23: 242-248
7. Sümegi V, Haszon I, Bereczki C, et al: Longterm follow-up after cyclophosphamide and cyclosporine-A therapy in steroid-dependent and-resistant nephrotic syndrome. Pediatr Nephrol 2008; 23: 1085-1092
8. Meyrier A: An update on the treatment options for focal segmental glomerulosclerosis. Expert Opin Pharmacother 2009; 10: 615-628
9. Duncan N, Dhaygude A, Owen J, et al: Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy. Nephrol Dial Transplant 2004; 19: 3062-3067
10. Choudhry S, Bagga A, Hari P, et al: Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial. Am J Kidney Dis 2009; 53: 760-769
11. Arikan H, Koc M, Cakalagaoglu F, et al: Tacrolimus rescue therapy in resistant or relapsing cases of primary glomerulonephritis. Am J Nephrol 2008; 21: 713-721
12. Xiayu Li, Heng Li, Huijuan Ye, et al: Tacrolimus therapy in adults with steroid-and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR. Am J Kidney Dis 2009; 54: 51-58
13. D'Agati VD, Fogo AB, Bruijin JA, et al: Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004; 43: 368-382
14. Abeyagunawardena AS, Sebire NJ, Risdon RA, et al: Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 2007; 22: 215-221
15. Ting LM, Gissot M, Coppi A, et al: Attenuated Plasmodium yoelii lacking purine nucleoside phosphorylase confer protective immunity. Nat Med 2008; 14: 954-958
16. Winn MP: 2007 Young Investigator Award: TRP'ing into a new era for glomerular disease. J Am Soc Nephrol 2008; 19: 1071-1075
17. Westhoff TH, Schmidt S, Zidek W, et al: Tacrolimus in steroid resistant and idiopathic steroid-dependent nephrotic syndrome. Clin Nephrol 2006; 65: 393-400
18. Segarra A, Vila J, Pou L, et al: Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or-dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 2002; 17: 655-662
19. Braun N, Schmutzler F, Lange C, et al: Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev 2008; 16: CD003233
20. Chen X, Chen N: The evaluation and treatment in adults with steroid-resistant focal segmental glomerulosclerosis. J Intern Med Concept Pract 2007; 2: 395-391.